@BoringBiz_ Layer the ability to focus and persist on top of curiosity and you supercharge it.
Curiosity gets you asking the right questions. But focus is what turns those questions into outcomes.
@nikillinit The revenue model & GTM model are the two things I see lacking the most. Few can answer both beyond “we’ll sell to payers”. That’s a channel, not a strategy. Who at the payer? Why do they care? What’s their willingness to pay? Is it repeatable? This is why many stall at <$1-5m
@StuartBlitz This is my number one question to understand when assessing the viability. Most only respond by defining the channel (i.e. payor, D2C, etc.), but then when pressed, can't justify how they would actually sell into that.
@BillDA It’s been 15+ years since I’ve done work for the government, but the main things were (1) limited tools/functionality you can use for security/procurement reasons & (2) most are optimized for long-term durability and minimizing maintenance. https://t.co/7O5uXdj7m9 is a counter ex
@nikillinit Been seeing this in the ketamine space, where an MSO does the legal, compliance, tech, etc. to enable Psych clinics to offer ketamine therapy
@xcbarnes@nikillinit Wonder how company's think about this. They could message that they're giving employees choice and give them ICHRA budget that matches their current spend (but lowers YoY increased spend), but then employee now has to pay more to maintain coverage
@jonostrower Is the bottleneck Clear? Or is it how many TSA screening lanes are open for Clear vs PreCheck? I’ve had that happen in DIA a few times and it’s always been because there’s far more screening lanes for PreCheck vs Clear.
@buccocapital What’s the best leading indicator for CS that leads to NDR? NPS correlation is questionable, but indexing on increasing NPS leads to over investment in factors that don’t lead to NDR.